347 related articles for article (PubMed ID: 17613544)
1. TGF-beta signaling alterations and susceptibility to colorectal cancer.
Xu Y; Pasche B
Hum Mol Genet; 2007 Apr; 16 Spec No 1(SPEC):R14-20. PubMed ID: 17613544
[TBL] [Abstract][Full Text] [Related]
2. Tgf-beta signaling alterations and colon cancer.
Bellam N; Pasche B
Cancer Treat Res; 2010; 155():85-103. PubMed ID: 20517689
[TBL] [Abstract][Full Text] [Related]
3. Somatic acquisition and signaling of TGFBR1*6A in cancer.
Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
[TBL] [Abstract][Full Text] [Related]
4. Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.
Zeng Q; Phukan S; Xu Y; Sadim M; Rosman DS; Pennison M; Liao J; Yang GY; Huang CC; Valle L; Di Cristofano A; de la Chapelle A; Pasche B
Cancer Res; 2009 Jan; 69(2):678-86. PubMed ID: 19147584
[TBL] [Abstract][Full Text] [Related]
5. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
[TBL] [Abstract][Full Text] [Related]
6. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
7. Role of TGF-beta in cancer and the potential for therapy and prevention.
Kaklamani VG; Pasche B
Expert Rev Anticancer Ther; 2004 Aug; 4(4):649-61. PubMed ID: 15270668
[TBL] [Abstract][Full Text] [Related]
8. TGFBR1 and cancer susceptibility.
Pasche B; Pennison MJ; Jimenez H; Wang M
Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747
[TBL] [Abstract][Full Text] [Related]
9. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
[TBL] [Abstract][Full Text] [Related]
10. Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.
Bian Y; Knobloch TJ; Sadim M; Kaklamani V; Raji A; Yang GY; Weghorst CM; Pasche B
Hum Mol Genet; 2007 Dec; 16(24):3128-35. PubMed ID: 17890272
[TBL] [Abstract][Full Text] [Related]
11. TGFBR1*6A is a potential modifier of migration and invasion in colorectal cancer cells.
Zhou R; Huang Y; Cheng B; Wang Y; Xiong B
Oncol Lett; 2018 Mar; 15(3):3971-3976. PubMed ID: 29467907
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.
Jung B; Staudacher JJ; Beauchamp D
Gastroenterology; 2017 Jan; 152(1):36-52. PubMed ID: 27773809
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development.
Sturlan S; Oberhuber G; Beinhauer BG; Tichy B; Kappel S; Wang J; Rogy MA
Carcinogenesis; 2001 Apr; 22(4):665-71. PubMed ID: 11285204
[TBL] [Abstract][Full Text] [Related]
14. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
[TBL] [Abstract][Full Text] [Related]
16. Role of the transforming growth factor-β signaling pathway in the pathogenesis of colorectal cancer.
Soleimani A; Pashirzad M; Avan A; Ferns GA; Khazaei M; Hassanian SM
J Cell Biochem; 2019 Jun; 120(6):8899-8907. PubMed ID: 30556274
[TBL] [Abstract][Full Text] [Related]
17. TGFBR1 signaling and breast cancer.
Moore-Smith L; Pasche B
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):89-95. PubMed ID: 21461994
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
19. TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.
Martinez-Canto A; Castillejo A; Mata-Balaguer T; Castillejo MI; Hernandez-Illan E; Irles E; Barbera VM; Egoavil C; Guarinos C; Alenda C; Ochoa E; Lazaro R; Fajardo S; Lacueva J; Calpena R; Soto JL
PLoS One; 2012; 7(1):e30812. PubMed ID: 22292045
[TBL] [Abstract][Full Text] [Related]
20. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.
Rosman DS; Phukan S; Huang CC; Pasche B
Cancer Res; 2008 Mar; 68(5):1319-28. PubMed ID: 18316594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
